My research focuses on therapeutically targeting one of the most elusive targets in cancer research, namely Ras. Our lab has discovered a bacterial protease we call the Ras/Rap1-specific protease or RRSP that has the natural activity to site-specifically cleave Ras and its close homolog Rap1.